HIV vaccine based on targeting maximized Gag and Nef to dendritic cells

Details for Australian Patent Application No. 2009270771 (hide)

Owner Baylor Research Institute

Inventors Flamar, Anne-laure; Banchereau, Jacques F.; Mead, Holly; Montes, Monica; Zurawski, Gerard; Cobb, Amanda

Agent Pizzeys

Pub. Number AU-B-2009270771

PCT Pub. Number WO2010/009346

Priority 61/081,234 16.07.08 US

Filing date 16 July 2009

Wipo publication date 21 January 2010

Acceptance publication date 23 August 2012

International Classifications

A61K 39/12 Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/02 Drugs for immunological or allergic disorders

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/009346 Priority application(s): WO2010/009346

23 August 2012 Application Accepted

  Published as AU-B-2009270771

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009270773-Transformation of glycerol and cellulosic materials into high energy fuels

2009270769-Tether handling for airborne electricity generators